FDA Drug Recalls

Recalls / Firms / Allergan Sales, LLC

Allergan Sales, LLC

13 FDA drug recalls on record.

DateClassDrugStatus
2019-03-19Class IICombiganTerminated
2017-10-19Class IIILumiganTerminated
2017-10-19Class IIICombiganTerminated
2017-05-01Class IIBlephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.Terminated
2017-03-16Class IIILumiganTerminated
2016-06-30Class IITAZORAC (tazarotene) Gel 0.05%, Rx only, packaged in 15 x 3.5 g professional sample contaiTerminated
2016-06-30Class IITAZORAC (tazarotene) Gel 0.05%, Rx only, For Dermatologic Use Only, Not for Ophthalmic UseTerminated
2016-05-10Class IITazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100gTerminated
2016-05-10Class IITazorac (tazarotene) Gel 0.05%, 15 x 3.5g, sample packs, Allergan Inc, Irvine, CA 92612. Terminated
2015-08-24Class IIRefresh Lacri-lubeTerminated
2015-08-24Class IIBLEPHAMIDE (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10 %/0Terminated
2015-08-24Class IIRefresh P.m.Terminated
2015-08-24Class IIFML (fluorometholone ophthalmic ointment) 0.1%, 3.5 g tube, Rx only, Allergan, Inc., IrvinTerminated